News 3|1|05

      home

      about us

      management

      board
      r & d

        pipeline
      EC Mechanism
      video
      news
      articles

      patents

      quarterly reports

      contact us
 
 


Click here for animation

 
  <  news & articles  >:

Cell>Point acquires N4 Technology License — 3|1|05

HOUSTON, Texas - March 1, 2005 - Cell>Point obtained the worldwide patent and technology license on February 14, 2005 to tatraazacyclopentadecane (N4) technology developed at The University of Texas M.D. Anderson Cancer Center.  N4 Technology will form the foundation for the development of Positron Emission Tomography imaging agents using generator based isotopes as well as compounds for imaging and treating neuroendocrine tumors and certain diseases affecting the central nervous system.

 
© copyright 2001-2007|Cell>Point L.L.C | all rights reserved | maintained by Link2City.com  

Terry Colip 

Home | About Us | Management Team | Scientific Advisory Board | Corporate fact Sheet
 EC Mechanism of Action | Video |  R & D | Agents Pipeline | News | Articles | Patents | Corp Financials | Contact Us